Sign in Subscribe
Genetic research

Breakthroughs in Cancer Gene Therapy: New Hopes for Osteosarcoma Patients

Strategic Insights

— 1 min read

Researchers from Hallym University have published a study on cancer gene therapy, highlighting the challenges and potential advancements in treating osteosarcoma, a common and aggressive bone cancer in children and adolescents. The study emphasizes the need for targeted therapies and immunotherapy to improve patient outcomes. With ongoing research and development of new therapies, the prognosis for osteosarcoma patients is expected to significantly improve.

Key Takeaways:

  • Osteosarcoma is a common and aggressive bone cancer in children and adolescents, affecting the long bones during growth spurts, with a 5-year survival rate of 60-70% for localized disease and much lower for advanced stages.
  • Current treatment involves a combination of surgery, chemotherapy, and radiotherapy, but comes with severe side effects, highlighting the need for more precise and less toxic therapies.
  • Targeted therapies, such as IGF-1R inhibitors and TKIs, and immunotherapy, including checkpoint inhibitors and CAR-T therapies, are promising areas of research aiming to attack cancer cells more precisely.
  • Other novel approaches, such as gene therapy and drug delivery systems, are being explored to improve treatment outcomes.
  • The study was funded by Hallym University Medical Center, and the research concluded that continued research and development of new therapies will significantly improve the outlook for osteosarcoma patients.
  • The study was published in Discover Oncology, a journal from Springer, with a free version available online.

Statistics:

  • 5-year survival rate for localized osteosarcoma: 60-70%
  • 5-year survival rate for advanced osteosarcoma: lower than 60-70%
  • Number of patients affected by osteosarcoma: not specified
  • Number of research studies exploring cancer gene therapy: not specified
  • Funding for the study: Hallym University Medical Center

Sources:

  • "Systemic strategies for osteosarcoma: advances and future directions." Discover Oncology, 2025,16(1):1-35. (https://doi.org/10.1007/s12672-025-02208-9)
  • NewsRx. Study Results from Hallym University in the Area of Cancer Gene Therapy Published (Systemic strategies for osteosarcoma: advances and future directions). Cancer Weekly. September 2, 2025; p 63.

Read more